Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
11 December, 2017 05:29 IST
Zydus Cadila receives approval from USFDA for Fingolimod capsules
Source: IRIS | 17 Jul, 2017, 08.30AM
Comments  |  Post Comment

Zydus Cadila has received the tentative approval from the USFDA to market Fingolimod Capsules, 0.5 mg. The drug is an immunomodulating drug, mostly used for treating multiple sclerosis  and will be produced at the group’s formulations manufacturing facility at the Pharma SEZ, in Ahmedabad.

The sales of Fingolimod Capsules is estimated at USD 2.1 billionn. Source: IMS Health, IMS National Sales Perspective Audit, MAT May 2017, extracted July 2017.
 
The group now has more than 120 approvals and has so far filed over 300 ANDAs since the commencement of the filing process in FY 2003-04.  

Shares of the company gained Rs 13.9, or 2.68%, to settle at Rs 532.50. The total volume of shares traded was 152,487 at the BSE (Friday).





Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Glenmark Pharma starts trial of investigational immuno-oncology agent GBR 1342 - 08-Dec-2017 10:45
TVS Motor acquires 14.78% stake in Ultraviolette Automotive - 08-Dec-2017 10:18
Emami to acquire 30% stake in Helios Lifestyle - 08-Dec-2017 10:04
Cyient enters into global alliance with EA Tech - 07-Dec-2017 15:35
SSWL expects 11% growth in order book in Q4FY18 - 07-Dec-2017 11:57
Tata Motors reports JLR sales at 52,332 units in Nov'17 - 07-Dec-2017 11:53
Larsen & Tubro bags order worth over Rs 16 bn - 07-Dec-2017 09:47
Bharti Airtel enters into partnership with Intex Tech - 06-Dec-2017 15:12
TVS Motor launches 'TVS Apache RR 310' - 06-Dec-2017 12:46
RInfra wins overseas EPC contracts of over worth Rs 50 bn - 06-Dec-2017 12:40
Suven Life Sciences secures 2 overseas product patents - 06-Dec-2017 10:35
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer